Open AccessThis article is
- freely available
Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology
Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 50001 Hradec Kralove, Czech Republic
Received: 16 January 2012; in revised form: 26 January 2012 / Accepted: 14 February 2012 / Published: 17 February 2012
Abstract: Alpha7 nicotinic acetylcholine receptor (α7 nAChR) is an important part of the cholinergic nerve system in the brain. Moreover, it is associated with a cholinergic anti-inflammatory pathway in the termination of the parasympathetic nervous system. Antagonists of α7 nAChR are a wide group represented by conotoxin and bungarotoxin. Even Alzheimer’s disease drug memantine acting as an antagonist in its side pathway belongs in this group. Agonists of α7 nAChR are suitable for treatment of multiple cognitive dysfunctions such as Alzheimer’s disease or schizophrenia. Inflammation or even sepsis can be ameliorated by the agonistic acting compounds. Preparations RG3487, SEN34625/WYE-103914, SEN12333, ABT-107, Clozapine, GTS-21, CNI-1493, and AR-R17779 are representative examples of the novel compounds with affinity toward the α7 nAChR. Pharmacological, toxicological, and medicinal significance of α7 nAChR are discussed throughout this paper.
Keywords: inflammation; cholinergic anti-inflammatory pathway; schizophrenia; Alzheimer’s disease; cognitive disorder; agonist; antagonist
Citations to this Article
Cite This Article
MDPI and ACS Style
Pohanka, M. Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology. Int. J. Mol. Sci. 2012, 13, 2219-2238.
Pohanka M. Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology. International Journal of Molecular Sciences. 2012; 13(2):2219-2238.
Pohanka, Miroslav. 2012. "Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology." Int. J. Mol. Sci. 13, no. 2: 2219-2238.